Bristol-Myers Squibb Determined on ImClone Systems Inc. (IMCL) Takeover, Sweetens Bid, Article Posted on BeaconEquity.com
Grabbing headlines in the pharmaceutical-biotech merger front, New York-based pharmaceuticals manufacturer Bristol-Myers announced it increased its offer for ImClone Systems Inc. to $62 a share in cash and will take the offer directly to shareholders of t
(EMAILWIRE.COM, September 24, 2008 ) DALLAS, Texas - BeaconEquity.com announces the publication of ‘Bristol-Myers Squibb Determined on ImClone Systems Inc. (IMCL) Takeover, Sweetens Bid’
Investors can view all of the investment articles for free by visiting:
http://www.beaconequity.com/m - Click on News and Commentary
Bristol-Myers Squibb Determined on ImClone Systems Inc. (IMCL) Takeover, Sweetens Bid
"Grabbing headlines in the pharmaceutical-biotech merger front, New York-based pharmaceuticals manufacturer Bristol-Myers announced it increased its offer for ImClone Systems Inc. to $62 a share in cash and will take the offer directly to shareholders of the New York oncology-drug specialist…
"Earlier this month, ImClone rejected Bristol-Myer's $60 per share bid, saying the figure substantially undervalued the company. Imclone said it was eyeing a higher bid from an unnamed buyer - a potential $70 a share bid…
"Bristol-Myers, which serves as U.S. marketer for the biotech group's only marketed product, currently owns approximately 16.6% of all outstanding shares of ImClone …
"Just like an embattled suitor, Bristol-Myers raised its offer to $62 per share, valued at approximately $4.7 billion, and said it will take the offer directly to shareholders. Also, Bristol-Myers said it will launch a proxy fight for control of ImClone's board, which has been chaired by activist investor Carl Icahn since late 2006 following a protracted battle with management…"
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at:
http://www.stockhideout.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Investors can view all of the investment articles for free by visiting:
http://www.beaconequity.com/m - Click on News and Commentary
Bristol-Myers Squibb Determined on ImClone Systems Inc. (IMCL) Takeover, Sweetens Bid
"Grabbing headlines in the pharmaceutical-biotech merger front, New York-based pharmaceuticals manufacturer Bristol-Myers announced it increased its offer for ImClone Systems Inc. to $62 a share in cash and will take the offer directly to shareholders of the New York oncology-drug specialist…
"Earlier this month, ImClone rejected Bristol-Myer's $60 per share bid, saying the figure substantially undervalued the company. Imclone said it was eyeing a higher bid from an unnamed buyer - a potential $70 a share bid…
"Bristol-Myers, which serves as U.S. marketer for the biotech group's only marketed product, currently owns approximately 16.6% of all outstanding shares of ImClone …
"Just like an embattled suitor, Bristol-Myers raised its offer to $62 per share, valued at approximately $4.7 billion, and said it will take the offer directly to shareholders. Also, Bristol-Myers said it will launch a proxy fight for control of ImClone's board, which has been chaired by activist investor Carl Icahn since late 2006 following a protracted battle with management…"
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at:
http://www.stockhideout.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Contact Information:
Beacon Equity Research
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Beacon Equity Research
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Press Release Keywords:
stock market, investing, investment ideas, market activity, small caps, micro caps, search engines, technology stocks, blue chips, marketing solutions, beaconequity.com, bristol myers squibb, imclone systems inc.
stock market, investing, investment ideas, market activity, small caps, micro caps, search engines, technology stocks, blue chips, marketing solutions, beaconequity.com, bristol myers squibb, imclone systems inc.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




